Compendium of Cancer Genome Aberrations

Changes

FEMA5:Volunteer Assignments and Opportunities (view source)

Revision as of 09:19, 27 February 2024

1,870 bytes added ,  09:19, 27 February 2024
no edit summary
Line 16: Line 16:  
!'''Date of Last Editor Review'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
!'''Notes'''
 +
|-
 +
|CHAPTER 2 (TUMOURS OF THE OVARY)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|[[FEMA5:Serous_cystadenoma,_adenofibroma,_and_surface_papilloma_of_the_ovary|Serous cystadenoma, adenofibroma, and surface papilloma of the ovary]]
 
|[[FEMA5:Serous_cystadenoma,_adenofibroma,_and_surface_papilloma_of_the_ovary|Serous cystadenoma, adenofibroma, and surface papilloma of the ovary]]
Line 786: Line 806:  
|
 
|
 
|
 
|
 +
|-
 +
|CHAPTER 3 (ENDOMETRIOSIS AND RELATED CONDITIONS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|[[FEMA5:Endometriosis_and_derived_tumours|Endometriosis and derived tumours]]
 
|[[FEMA5:Endometriosis_and_derived_tumours|Endometriosis and derived tumours]]
Line 797: Line 837:  
|
 
|
 
|
 
|
 +
|-
 +
|CHAPTER 4 (TUMOURS OF THE PERITONEUM)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|[[FEMA5:Adenomatoid_tumour_|Adenomatoid tumour]]
 
|[[FEMA5:Adenomatoid_tumour_|Adenomatoid tumour]]
Line 1,062: Line 1,122:  
|
 
|
 
|-
 
|-
−
|[[FEMA5:Serous_adenofibroma_and_papilloma_of_the_fallopian_tube|Serous adenofibroma and papilloma of the fallopian tube]]
+
|CHAPTER 5 (TUMOURS OF THE FALLOPIAN TUBE)
−
|Disease
+
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|[[FEMA5:Serous_borderline_tumour_of_the_fallopian_tube|Serous borderline tumour of the fallopian tube]]
+
|[[FEMA5:Serous_adenofibroma_and_papilloma_of_the_fallopian_tube|Serous adenofibroma and papilloma of the fallopian tube]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,084: Line 1,153:  
|
 
|
 
|-
 
|-
−
|[[FEMA5:High-grade_serous_carcinoma_of_the_fallopian_tube|High-grade serous carcinoma of the fallopian tube]]
+
|[[FEMA5:Serous_borderline_tumour_of_the_fallopian_tube|Serous borderline tumour of the fallopian tube]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:High-grade_serous_carcinoma_of_the_fallopian_tube|High-grade serous carcinoma of the fallopian tube]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,215: Line 1,295:  
|
 
|
 
|
 
|
 +
|-
 +
|CHAPTER 6 (TUMOURS OF THE BROAD LIGAMENT AND OTHER UTERINE LIGAMENTS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|[[FEMA5:Leiomyoma_of_the_broad_ligament_and_other_uterine_ligaments|Leiomyoma of the broad ligament and other uterine ligaments]]
 
|[[FEMA5:Leiomyoma_of_the_broad_ligament_and_other_uterine_ligaments|Leiomyoma of the broad ligament and other uterine ligaments]]
Line 1,303: Line 1,403:  
|
 
|
 
|
 
|
 +
|-
 +
|CHAPTER 7 (TUMOURS OF THE UTERINE CORPUS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|[[FEMA5:Endometrial_hyperplasia_without_atypia|Endometrial hyperplasia without atypia]]
 
|[[FEMA5:Endometrial_hyperplasia_without_atypia|Endometrial hyperplasia without atypia]]
Line 1,623: Line 1,743:  
|
 
|
 
|-
 
|-
−
|[[FEMA5:Exaggerated_placental_site_reaction|Exaggerated placental site reaction]]
+
|CHAPTER 8 (GESTATIONAL TROPHOBLASTIC DISEASE)
−
|Disease
+
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|[[FEMA5:Placental_site_nodule_and_plaque|Placental site nodule and plaque]]
+
|[[FEMA5:Exaggerated_placental_site_reaction|Exaggerated placental site reaction]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Placental_site_nodule_and_plaque|Placental site nodule and plaque]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,732: Line 1,872:  
|
 
|
 
|
 
|
 +
|-
 +
|CHAPTER 9 (TUMOURS OF THE UTERINE CERVIX)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|[[FEMA5:Squamous_metaplasia|Squamous metaplasia]]
 
|[[FEMA5:Squamous_metaplasia|Squamous metaplasia]]
Line 2,073: Line 2,233:  
|
 
|
 
|
 
|
 +
|-
 +
|CHAPTER 10 (TUMOURS OF THE VAGINA)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|[[FEMA5:Squamous_papilloma_of_the_vagina|Squamous papilloma of the vagina]]
 
|[[FEMA5:Squamous_papilloma_of_the_vagina|Squamous papilloma of the vagina]]
Line 2,327: Line 2,507:  
|
 
|
 
|-
 
|-
−
|[[FEMA5:Seborrhoeic_keratosis|Seborrhoeic keratosis]]
+
|CHAPTER 11 (TUMOURS OF THE VULVA)
−
|Disease
+
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|[[FEMA5:Condyloma_acuminatum|Condyloma acuminatum]]
+
|[[FEMA5:Seborrhoeic_keratosis|Seborrhoeic keratosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 2,349: Line 2,538:  
|
 
|
 
|-
 
|-
−
|[[FEMA5:Squamous_intraepithelial_lesions,_HPV-associated,_of_the_vulva|Squamous intraepithelial lesions, HPV-associated, of the vulva]]
+
|[[FEMA5:Condyloma_acuminatum|Condyloma acuminatum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Squamous_intraepithelial_lesions,_HPV-associated,_of_the_vulva|Squamous intraepithelial lesions, HPV-associated, of the vulva]]
 
|Disease
 
|Disease
 
|
 
|
Line 2,535: Line 2,735:  
|
 
|
 
|
 
|
 +
|-
 +
|CHAPTER 12 (NEUROENDOCRINE NEOPLASIA)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|[[FEMA5:Neuroendocrine_tumour|Neuroendocrine tumour]]
 
|[[FEMA5:Neuroendocrine_tumour|Neuroendocrine tumour]]
Line 2,579: Line 2,799:  
|
 
|
 
|
 
|
 +
|-
 +
|CHAPTER 13 (HAEMATOLYMPHOID PROLIFERATIONS AND NEOPLASIA)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|[[FEMA5:Florid_reactive_lymphoid_hyperplasia|Florid reactive lymphoid hyperplasia]]
 
|[[FEMA5:Florid_reactive_lymphoid_hyperplasia|Florid reactive lymphoid hyperplasia]]
Line 2,646: Line 2,886:  
|
 
|
 
|-
 
|-
−
|[[FEMA5:Lipoma_|Lipoma]]
+
|CHAPTER 14 (MESENCHYMAL TUMOURS OF THE LOWER GENITAL TRACT)
−
|Disease
+
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|[[FEMA5:Lipoblastoma-like_tumour_of_the_vulva|Lipoblastoma-like tumour of the vulva]]
+
|[[FEMA5:Lipoma_|Lipoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Lipoblastoma-like_tumour_of_the_vulva|Lipoblastoma-like tumour of the vulva]]
 
|Disease
 
|Disease
 
|
 
|
Line 2,942: Line 3,202:  
|
 
|
 
|
 
|
 +
|-
 +
|CHAPTER 15 (MELANOCYTIC LESIONS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|[[FEMA5:Acquired_melanocytic_naevus|Acquired melanocytic naevus]]
 
|[[FEMA5:Acquired_melanocytic_naevus|Acquired melanocytic naevus]]
Line 3,008: Line 3,288:  
|
 
|
 
|
 
|
 +
|-
 +
|CHAPTER 16 (METASTASIS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|[[FEMA5:Metastasis_to_the_lower_female_genital_tract|Metastasis to the lower female genital tract]]
 
|[[FEMA5:Metastasis_to_the_lower_female_genital_tract|Metastasis to the lower female genital tract]]
Line 3,019: Line 3,319:  
|
 
|
 
|
 
|
 +
|-
 +
|CHAPTER 17 (GENETIC TUMOUR SYNDROMES OF THE FEMALE GENITAL TRACT)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|[[FEMA5:BRCA1/2-associated_hereditary_breast_and_ovarian_cancer_syndrome|BRCA1/2-associated hereditary breast and ovarian cancer syndrome]]
 
|[[FEMA5:BRCA1/2-associated_hereditary_breast_and_ovarian_cancer_syndrome|BRCA1/2-associated hereditary breast and ovarian cancer syndrome]]
Line 3,131: Line 3,451:  
|-
 
|-
 
|[[FEMA5:Hereditary_leiomyomatosis_and_renal_cell_carcinoma|Hereditary leiomyomatosis and renal cell carcinoma]]
 
|[[FEMA5:Hereditary_leiomyomatosis_and_renal_cell_carcinoma|Hereditary leiomyomatosis and renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|Other genetic tumour syndromes of the female genital tract
 
|Disease
 
|Disease
 
|
 
|
Retrieved from "https://content.ccga.io/index.php/Special:MobileDiff/14264"